Powered by The Dementia Service, the leading UK Private Memory Clinic

Side effects of dementia medication

Reading time: 4 minutes Last reviewed: 8th May 2026 Clinically reviewed by The Dementia Service

In plain English

Cholinesterase Inhibitors and Memantine are generally well-tolerated. Most side effects are gastrointestinal, mild and transient. This page sets out what to expect, when to call your prescriber, and what helps.

The common pattern

Most side effects of Cholinesterase Inhibitors (Donepezil, Galantamine, Rivastigmine) occur in the first 1 to 2 weeks of starting or increasing the dose, then settle. Most are gastrointestinal. Memantine has fewer side effects.

By system

Gastrointestinal (commonest)

Neurological

Cardiovascular

Skin (Rivastigmine patch)

Other

Memantine side effects

Memantine has a different profile, with fewer side effects than the Cholinesterase Inhibitors:

What helps

When to contact your prescriber

Same-day contact for any of the following:

Routine review for ongoing tolerability concerns at the next scheduled appointment, or sooner if persistent.

Stopping medication

If side effects are intolerable despite reasonable adjustment, the medicine can be stopped. Sudden discontinuation can sometimes produce a step-down in cognitive function over the following weeks. A planned, supervised taper is preferred. Discuss with your prescriber.

Frequently asked questions

How long do side effects last?

Most gastrointestinal side effects of Cholinesterase Inhibitors settle within 1 to 2 weeks of starting or each dose increase. Side effects that persist beyond a month at a stable dose are unusual.

Should I take with food?

Yes, for Cholinesterase Inhibitors. The exception is the Rivastigmine patch, which does not interact with food intake. Donepezil tablets are often taken at bedtime; Galantamine with breakfast.

Can I switch if side effects are bad?

Yes. Switching from one Cholinesterase Inhibitor to another (particularly to the Rivastigmine patch) often substantially improves tolerability.

Will the medicine make me dizzy enough to fall?

Falls are more common in older adults on Cholinesterase Inhibitors than on placebo, but the absolute increase is small. A falls assessment with attention to medication, vision, footwear and home environment reduces risk.

Can I drink alcohol?

Small amounts of alcohol are generally fine. Heavy or regular drinking is discouraged because it interacts with the medicine and accelerates cognitive decline.

What to do next

  1. Keep a brief note of any side effects in the first month to share at the review.
  2. Maintain hydration and smaller frequent meals if appetite is reduced.
  3. Contact your prescriber promptly for any of the same-day concerns above.

References

  1. BNF Cholinesterase Inhibitor and Memantine monographs.
  2. NICE TA217.
  3. Cochrane reviews of cholinesterase inhibitors in Alzheimer's Disease.
  4. Electronic Medicines Compendium product information for Donepezil, Galantamine, Rivastigmine, Memantine.